Adolescence, schizophrenia and drug abuse: Interactive vulnerability. A hypothesis;Adolescentie, schizofrenie en drugs: Interacterende kwetsbaarheid. Een hypothese

Tijdschrift voor Psychiatrie

Volumn 49, Issue 3, 2007, Pages 169-178

  Van Nimwegen, Lonneke ^a   De Haan, L ^b   Van Beveren, N ^a   Van Den Brink, W ^b,c   Linszen, D ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

Author keywords

Adolescent; Dopamine; Drug usage; Neuronal development; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; GLUTAMIC ACID; NEUROLEPTIC AGENT;

ADOLESCENT HEALTH; ANHEDONIA; ARTICLE; BRAIN CORTEX; CHILD PSYCHIATRY; CORRELATION ANALYSIS; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG DEPENDENCE; DYSPHORIA; HUMAN; LIMBIC SYSTEM; MEDICAL LITERATURE; NEUROBIOLOGY; NEUROTRANSMISSION; PATHOGENESIS; PATIENT COMPLIANCE; PROBABILITY; PSYCHOSIS; PSYCHOSOCIAL DEVELOPMENT; RISK FACTOR; SCHIZOPHRENIA; WELLBEING;

ADOLESCENT; HUMANS; REINFORCEMENT (PSYCHOLOGY); SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 34147148596     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Addington, J., & Duchak, V. (1997). Reasons for substance use in schizophrenia. Acta Psychiatrica Scandinavica, 96, 329-333.
2. Adriani, W., & Laviola, G. (2004). Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behavioural Pharmacology, 15, 341-352.
3. Adriani, W., Spijker, S., Deroche-Gamonet, V., e.a. (2003). Evidence for enhanced neurobehavioral vulnerability to nicotine duting periadolescence in rats. The Journal of Neuroscience, 23, 4712-4716.
4. Akbarian, S., Kim, J.J., Potkin, S.G., e.a. (1996). Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Archives of General Psychiatry, 53, 425-436.
5. Ameri, A. (1999). The effects of cannabinoids on the btain. Progress in Neurobiology, 58, 315-348.
6. Andreasson, S., Allebeck, P., Engstrom, A., e.a. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, 2, 1483-1486.
7. Anthony, J., & Helzer, J. (1991). Syndromes of drug abuse and dependence, in psychiatric disorders in America: the epidemiological catchment area study. In L.N. Robins & D.A. Regier (Red.), Psychiatric Disorders in America (pp. 116-154). New York: Free Press.
8. Anthony, J.C., & Petronis, K.R. (1995). Early-onset drug use and risk of later drug problems. Drug and Alcohol Dependence, 40, 9-15.
9. Aouizerate, B., Guehl, D., Cuny, E., e.a. (2004). Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Progress in Neurobiology, 72, 195-221.
10. Arndt, S., Tyrrell, G., Flaum, M., e.a. (1992). Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychological Medicine, 22, 379-388.
11. Arnett, J. (1992). Reckless behavior in adolescence: a developmental perspective. Development Review, 12, 339-373.
12. Arseneault, L., Cannon, M., Poulton, R., e.a. (2004). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212-1213.
13. Awad, A.G., & Voruganti, L.N. (2004). New antipsychotics, compliance, quality of life, and subjective tolerability - are patients better off? Canadian Journal of Psychiatry, 49, 297-301.
14. Bartzokis, G. (2002). Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology, 27, 672-683.
15. Blum, K., Braverman, E.R., Holder, J.M., e.a. (2000). Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of Psychoactive Drugs, 32(Suppl. i-iv), 1-112.
16. Brüne, M. (2004). Schizophrenia-an evolutionary enigma? Neuroscience and Biobehavioral Reviews, 28, 41-53.
17. Caspi, A., Moffitt, T.E., Cannon, M., e.a. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57, 1117-1127.
18. Chambers, R.A., Krystal, J.H., & Self, D.W. (2001). A neurobiological basis for substance abuse comotbidity in schizophrenia. Biological Psychiatry, 50, 71-83.
19. Chambers, R.A., Taylor, J.R., & Potenza, M.N. (2003). Developmental neutocircuitry of motivation in adolescence: a critical period of addiction vulnetability. The American Journal of Psychiatry, 160, 1041-1052.
20. Chefer, V.I., Zakharova, I., & Shippenberg, T.S. (2003). Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions. The Journal of Neuroscience, 23, 3076-3084.
21. Childress, A.R., Mozley, P.D., McElgin, W., e.a. (1999). Limbic activation during cue-induced cocaine craving. The American Journal of Psychiatry, 156, 11-18.
22. Cohen, J.D., & Servan-Schreiber, D. (1992). Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychological Review, 99, 45-77.
23. Dervaux, A., Bayle, F.J., Laqueille, X., e.a. (2001). Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia? The American Journal of Psychiatry, 158, 492-494.
24. Dixon, L. (1999). Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research, 35 (Suppl.), S93-S100.
25. Dixon, L., Haas, G., Weiden, P.J., e.a. (1991). Drug abuse in schizophrenic patients: clinical correlates and reasons for use. The American Journal of Psychiatry, 148, 224-230.
26. Duke, P.J., Pantelis, C., McPhillips, M.A., e.a. (2001). Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. The British Journal of Psychiatry, 179, 509-513.
27. Ellison, G.D., & Eison, M.S. (1983). Continuous amphetamine intoxication: an animal model of the acute psychotic episode. Psychological Medicine, 13, 751-761.
28. Feinberg, I. (1982-1983). Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research, 17, 319-334.
29. Fowler, I.L., Carr, V.J., Carter, N.T., e.a. (1998). Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin, 24, 443-455.
30. Franken, I.H., Hendriks, V.M., Stam, C.J., e.a. (2004). A role for dopamine in the processing of drug cues in heroin dependent patients. European Neuropsychopharmacology, 14, 503-508.
31. Gelber, E.I., Kohler, C.G., Bilker, W.B., e.a. (2004). Symptom and demographic profiles in first-episode schizophrenia. Schizophrenia Research, 67, 185-194.
32. Goldstein, R.Z., & Volkow, N.D. (2002). Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. The American Journal of Psychiatry, 159, 1642-1652.
33. Grant, B.F. (1997). Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. Journal of Studies on Alcohol, 58, 464-473.
34. Gut-Fayand, A., Dervaux, A., Olie, J.P., e.a. (2001). Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Research, 102, 65-72.
35. Haan, L. de, van Bruggen, M., Lavalaye, J., e.a. (2003). Subjective experience and D2 receptor occupancy on patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized double-blind study. The American Journal of Psychiatry, 160, 303-309.
36. Haan, L. de, & Kapur, S. (2003). Dopamine, importantie en psychose; een theorie. Maandblad Geestelijke volksgezondheid, 3, 228-235.
37. Haan, L. de, Lavalaye, J., van Bruggen, M., e.a. (2004). Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Canadian Journal of Psychiatry, 49, 290-296.
38. Häfner, H. (2003). Prodrome, onset and early course of schizophrenia. In R. Murray, P. Jones, E. Susser e.a. (Red.), The Epidemiology of Schizophrenia (pp. 124-148). Cambridge: Cambridge University Press.
39. Hambrecht, M., & Häfner, H. (1997). Sensitivity and specificity of relatives' reports on the early course of schizophrenia. Psychopathology, 30, 12-19.
40. Henquet, C., Murray, R., Linszen, D., e.a. (2005). The environment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin, 31, 608-612.
41. Hoffman, R.E., &McGlashan, T.H. (1997). Synaptic elimination, neurodevelopment, and the mechanism of hallucinated 'voices' in schizophrenia. The American Journal of Psychiatry, 154, 1683-1689.
42. Hutchison, K.E., Wooden, A., Swift, R.M., e.a. (2003). Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology, 28, 1882-1888.
43. Jeffery, K.J., & Reid, I.C. (1997). Modifiable neuronal connections: an overview for psychiatrists. The American Journal of Psychiatry, 154, 156-164.
44. Kandel, D.B., Yamaguchi, K., & Chen, K. (1992). Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. Journal of Studies on Alcohol, 53, 447-457.
45. Katsanis, J., Iacono, W.G., & Beiser, M. (1990). Anhedonia and perceptual aberration in first-episode psychiatric patients and their relatives. Journal of Abnormal Psychology, 99, 202-206.
46. Keshavan, M.S., Anderson, S., & Pettegrew, J.W. (1994). Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. Journal of Psychiatric Research, 28, 239-265.
47. Larson, R.W., Moneta, G., Richards, M.H., e.a. (2002). Continuity, stability, and change in daily emotional experience across adolescence. Child Development, 73, 1151-1165.
48. Larson, R., & Richards, M. (1994). Divergent realities: the emotional lives of mothers, fathers and adolescents. New York: Basic books.
49. Laviola, G., Macri, S., Morley-Fletcher, S., e.a. (2003). Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neuroscience and Biobehavioral Reviews, 27, 19-31.
50. Li, X., Stanton, B., Cottrell, L., e.a. (2001). Patterns of initiation of sex and diug-related activities among urban low-income African-American adolescents. The Journal of Adolescent Health, 28, 46-54.
51. Lieberman, J.A., Kinon, B.J., & Loebel, A.D. (1990). Dopaminergic mechanisms in idiopathic and drug-induced psychosis. Schizophrenia Bulletin, 16, 97-110.
52. Lillrank, S.M., Oja, S.S., Saransaari, P., e.a (1991). Animal models of amphetamine psychosis: neurotransmitter release from rat brain slices. The International Journal of Neuroscience, 60, 1-15.
53. Linszen, D.H., Dingemans, P.M., Lenior, M.E., e.a. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273-279.
54. Longhurst, J.G., Boutros, N.N., & Bowers, M.B. (1997). Cannabis-induced chronic psychosis: an underacknowledged disorder? The Australian and New Zealand Journal of Psychiatry, 31, 304-305.
55. Mathers, D.C., Ghodse, A.H., Caan, A.W., e.a. (1991). Cannabis use in a large sample of acute psychiatric admissions. British Journal of Addiction, 86, 779-784.
56. McGlashan, T.H., & Hoffman, R.E. (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Archives of General Psychiatry, 57, 637-648.
57. Mueser, K.T., Drake, R.E., Wallach, M.A., e.a. (1998). Dual diagnosis: a review of etiological theories. Addictive Behaviors, 23, 717-734.
58. Mueser, K.T., Yarnold, P.R., Levinson, D.F., e.a. (1990). Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophrenia Bulletin, 16, 31-56.
59. Murray, R., Grech, A., Philips, P., e.a. (2003). What is the relationship between substance abuse and schizophrenia? In R. Murray, P. Jones, E. Susser e.a. (Red.), The epidemiology of schizophrenia (pp. 317-343), Cambridge: Cambridge University Press.
60. Naber, D. (1998). Subjective experiences of schizophrenic patients treated with antipsychotic medication. International Clinical Psychopharmacology, 13, 41-45.
61. Naber, D., Riedel, M., Klimke, A., e.a. (2005). Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatrica Scandinavica, 11, 106-115.
62. Naber, D., Moritz, S., Lambert, M., e.a. (2001). Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophrenia Research, 50, 79-88.
63. Paillere-Martinot, M.L., Aubin, F., Martinot, J.L., e.a. (2000). A prognostic study of clinical dimensions in adolescent-onset psychoses. Schizophrenia Bulletin, 26, 789-799.
64. Randall, P.L. (1998). Schizophrenia as a consequence of brain evolution. Schizophrenia Research, 30, 143-148.
65. Rolfe, M., Tang, C.M., Sabally, S., e.a. (1993). Psychosis and cannabis use in The Gambia. A case-control study. The British Journal of Psychiatry, 163, 798-801.
66. Saiz, P.A., G-Portilla, M.P., Paredes, B., e.a. (2003). Use of cocaine by secondary school students in northern Spain. European Addiction Research, 9, 138-143.
67. Sato, M., Numachi, Y., & Hamamura, T. (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophrenia Bulletin, 18, 115-122.
68. Schneier, F.R., & Siris, S.G. (1987). A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. The Journal of Nervous and Mental Disease, 175, 641-652.
69. Schultz, W. (2001). Reward signaling by dopamine neurons. The Neuroscientist, 7, 293-302.
70. Seibyl, J.P., Satel, S.L., Anthony, D., e.a. (1993). Effects of cocaine on hospital course in schizophrenia. The Journal of Nervous and Mental Disease, 181, 31-37.
71. Shaner, A., Eckman, T., Roberts, L.J., e.a. (2003). Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psychiatric Services, 54, 1287-1289.
72. Smelson, D.A., Losonczy, M.F., Davis, C.W., e.a. (2002). Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Canadian Journal of Psychiatry, 47, 671-675.
73. Soyka, M., Albus, M., Immler, B., e.a (2001). Psychopathology in dual diagnosis and non-addicted schizophrenics - are there differences? European Archives of Psychiatry and Clinical Neuroscience, 251, 232-238.
74. Stanton, B., Li, X., Cottrell, L., e.a. (2001). Early initiation of sex, drug-related risk behaviors, and sensation-seeking among urban, low-income African-American adolescents. Journal of the National Medical Association, 93, 129-138.
75. Taioli, E., & Wynder, E.L. (1991). Effect of the age at which smoking begins on frequency of smoking in adulthood. The New England Journal of Medicine, 325, 968-969.
76. Tkachev, D., Mimmack, M.L., Ryan, M.M. e.a. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet, 362, 798-805.
77. Volkow, N.D., Fowler, J.S., Wang, G.J., e.a. (2002). Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiology of Learning and Memory, 78, 610-624.
78. Voruganti, L., Cortese, L., Oyewumi, L., e.a. (2000). Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophrenia Research, 43, 135-145.
79. Voruganti, L.N., Slomka, P., Zabel, P., e.a. (2001). Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Research, 107, 173-177.
80. Warner, L.A., Kessler, R.C., Hughes, M., e.a. (1995). Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 52, 219-229.
81. Weickert, C.S., & Weinberger, D.R. (1998). A candidate molecule approach to defining developmental pathology in schizophrenia. Schizophrenia Bulletin, 24, 303-316.
82. Weiser, M., Reichenberg, A., Rabinowitz, J., e.a. (2003). Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia. Biological Psychiatry, 54, 655-660.
83. Wenger, T., Moldrich, G., & Furst, S. (2003). Neuromorphological background of cannabis addiction. Brain Research Bulletin, 61, 125-128.